Search hospitals > California > Anaheim
Kaiser Permanente-Anaheim
Claim this profileAnaheim, California 92806
Global Leader in Parotid Gland Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Relapse
136 reported clinical trials
11 medical researchers
Summary
Kaiser Permanente-Anaheim is a medical facility located in Anaheim, California. This center is recognized for care of Parotid Gland Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Relapse and other specialties. Kaiser Permanente-Anaheim is involved with conducting 136 clinical trials across 357 conditions. There are 11 research doctors associated with this hospital, such as Robert M. Cooper, Helen H. Moon, Gary L. Buchschacher, and Richard Green, MD.Area of expertise
1Parotid Gland Cancer
Global LeaderStage IV
Stage III
Stage I
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Robert M. CooperKaiser Permanente Downey Medical Center8 years of reported clinical research
Expert in Cystic Tumor
Expert in Neuroblastoma
49 reported clinical trials
95 drugs studied
Helen H. MoonKaiser Permanente-Riverside8 years of reported clinical research
Studies Parotid Gland Cancer
Studies Kidney Cancer
13 reported clinical trials
23 drugs studied
Gary L. BuchschacherKaiser Permanente-Anaheim7 years of reported clinical research
Studies Colon Cancer
Studies Cervical Adenocarcinoma
14 reported clinical trials
34 drugs studied
Richard Green, MDKaiser Permanente Los Angeles Medical Center9 years of reported clinical research
Studies Glioblastoma
Studies Brain Tumor
11 reported clinical trials
23 drugs studied
Clinical Trials running at Kaiser Permanente-Anaheim
Lung Cancer
Breast Cancer
Parotid Gland Cancer
Non-Small Cell Lung Cancer
Breast cancer
Testicular cancer
Squamous Cell Carcinoma
Bladder Cancer
Cancer
Skin Cancer
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Stereotactic Radiosurgery vs Whole-Brain Radiotherapy
for Brain Metastasis from Lung Cancer
This phase III trial compares the effect of stereotactic radiosurgery to standard of care memantine and whole brain radiation therapy that avoids the hippocampus (the memory zone of the brain) for the treatment of small cell lung cancer that has spread to the brain. Stereotactic radiosurgery is a specialized radiation therapy that delivers a single, high dose of radiation directly to the tumor and may cause less damage to normal tissue. Whole brain radiation therapy delivers a low dose of radiation to the entire brain including the normal brain tissue. Hippocampal avoidance during whole-brain radiation therapy (HA-WBRT) decreases the amount of radiation that is delivered to the hippocampus which is a brain structure that is important for memory. The drug, memantine, is also often given with whole brain radiotherapy because it may decrease the risk of side effects related to thinking and memory. Stereotactic radiosurgery may decrease side effects related to memory and thinking compared to standard of care HA-WBRT plus memantine.
Recruiting2 awards Phase 315 criteria
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting2 awards Phase 312 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Kaiser Permanente-Anaheim?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.